Paying physicians to prescribe generic drugs and follow-on biologics in the United States

PLoS Med. 2015 Mar 17;12(3):e1001802. doi: 10.1371/journal.pmed.1001802. eCollection 2015 Mar.


Aaron Kesselheim and colleagues examine potential strategies to promote greater prescribing of generic drugs and follow-on biologics.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Attitude of Health Personnel
  • Biological Products* / economics
  • Biological Products* / therapeutic use
  • Cost-Benefit Analysis
  • Drug Prescriptions* / economics
  • Drugs, Generic* / economics
  • Drugs, Generic* / therapeutic use
  • Health Care Costs*
  • Humans
  • Physicians*
  • Practice Patterns, Physicians'*
  • Salaries and Fringe Benefits*
  • Surveys and Questionnaires
  • United States


  • Biological Products
  • Drugs, Generic

Grants and funding

ASK’s work is supported by an Ignition Award from the Harvard Program in Therapeutic Science. ASK is a Greenwall Faculty Scholar in Bioethics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.